The DOI matches its Crossref record.
Minimizing the Impact of Drug-Resistant Streptococcus pneumoniae (DRSP): A Strategy From the DRSP Working Group
Abstract
Emergence of drug-resistant Streptococcus pneumoniae (DRSP) presents a challenge to the medical and public health communities since the magnitude of the problem is not known, the clinical impact of DRSP infections is not well described, national vaccination rates are low, and antimicrobial drugs are often used excessively and inappropriately. To address the problem of DRSP, a working group by Centers for Disease Control and Prevention was formed in June 1994 consisting of public health practitioners, health care providers, and clinical laboratorians representing state and federal agencies and various professional organizations. Through periodic open meetings, the working group has developed a strategy for surveillance, investigation, prevention, and control of infections due to DRSP. The strategy focuses on (1) implementing an electronic laboratory-based surveillance (ELBS) system for reporting invasive DRSP infections and providing clinically relevant feedback to clinicians, (2) identifying risk factors and outcomes of DRSP infection, (3) increasing pneumococcal vaccination, and (4) promoting judicious antimicrobial drug use. Data received through ELBS will be used to make timely estimates of the community-specific prevalence of drug-resistant pneumococci. National, regional, and local trends will be made available to health care providers and clinicians to promote optimal antimicrobial drug use and increased vaccination in targeted areas. Once in operation, the ELBS network will be adaptable to other diseases, improving the comprehensiveness and timeliness of public health surveillance. The intended outcome of the strategy is to reduce complications of DRSP infection, such as long-term sequelae of infection, health care expenditures, morbidity, and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Antibiotic Prescribing for Children With Colds, Upper Respiratory Tract Infections, and Bronchitis
Nyquist, A.-C. (1998) · JAMA · doi:10.1001/jama.279.11.875 · Cited by 679
Reducing Antibiotic Use in Children: A Randomized Trial in 12 Practices
Finkelstein, J. A., Davis, R. L., Dowell, S. F., Metlay, J. P., Soumerai, S. B., Rifas-Shiman, S. L., Higham, M., Miller, Z., Miroshnik, I., Pedan, A., et al. (2001) · Pediatrics · doi:10.1542/peds.108.1.1 · Cited by 674
Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroëdan, F., Bouvenot, G., & Eschwége, E. (1998) · JAMA · doi:10.1001/jama.279.5.365 · Cited by 545
Trends in Antimicrobial Prescribing Rates for Children and Adolescents
McCaig, L. F. (2002) · JAMA · doi:10.1001/jama.287.23.3096 · Cited by 517
Metadata
- Authors
- Jernigan, D. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1996-01-17
- Volume
- 275
- Issue
- 3
- Pages
- 206
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2009939166
- Cited by
- 163
- References
- 0
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minimizing the Impact of Drug-Resistant Streptococcus pneumoniae (DRSP): A Strategy From the DRSP Working Group. https://app.cochat.ai/papers/10.1001/jama.1996.03530270046030
- The paper
- Jernigan, D. B. (1996). Minimizing the Impact of Drug-Resistant Streptococcus pneumoniae (DRSP): A Strategy From the DRSP Working Group. JAMA. https://doi.org/10.1001/jama.1996.03530270046030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.